Stocks Blog: Traders in 'wait and see' mode ahead of US Fed rate decision, G20 gathering

  • 'Monster stock' in China has been on big high —  but company denies it has received hemp license 
  • Chinese drug maker soars on malaria treatment hype even as it warns against risk
Topic |   Stocks Blog

Good day, traders.

Catch up below on a busy day in Hong Kong and mainland markets. If you have questions, please send them to
[email protected]
. And welcome to our first reader from Portugal.

Yujing Liu and Deb Price